Background and Objectives: Pseudomonas aeruginosa is the most frequent opportunistic pathogen isolated from the sputum of patients with cystic fibrosis (CF).
Roya Rafiee +3 more
doaj
Acquired AmpC β-Lactamases among Enterobacteriaceae from Healthy Humans and Animals, Food, Aquatic and Trout Aquaculture Environments in Portugal. [PDF]
Gonçalves Ribeiro T +3 more
europepmc +1 more source
Novel monoclonal antibodies for immunodetection of AmpC β-lactamases. [PDF]
Bielskė K +6 more
europepmc +1 more source
AmpC β-lactamases detected in Southeast Asian Escherichia coli and Klebsiella pneumoniae. [PDF]
Roberts T +10 more
europepmc +1 more source
A Primer on AmpC β-Lactamases: Necessary Knowledge for an Increasingly Multidrug-resistant World. [PDF]
Tamma PD +5 more
europepmc +1 more source
Evolution of β-Lactam Antibiotic Resistance in <i>Proteus</i> Species: From Extended-Spectrum and Plasmid-Mediated AmpC β-Lactamases to Carbapenemases. [PDF]
Bedenić B +3 more
europepmc +1 more source
ESBL and AmpC β-Lactamases in Clinical Strains of Escherichia coli from Serra da Estrela, Portugal. [PDF]
Oliveira C +5 more
europepmc +1 more source
Characterizing Escherichia coli carrying plasmid-mediated AmpC β-lactamases to optimize detection in a diagnostic laboratory setting. [PDF]
Teng J +8 more
europepmc +1 more source
Phenotypic and Genotypic Identification of Four Cases of Plasmid-Mediated AmpC β-Lactamases-Producing Escherichia coli Admitted to a Tertiary Centre. [PDF]
Salmuna ZN +3 more
europepmc +1 more source
Relative inhibitory activities of newly developed diazabicyclooctanes, boronic acid derivatives, and penicillin-based sulfone β-lactamase inhibitors against broad-spectrum AmpC β-lactamases. [PDF]
Le Terrier C +4 more
europepmc +1 more source

